FDA Inspection 1326340 — Victoria E. Wang, MD, PhD

Victoria E. Wang, MD, PhD — FEI 3044683552

The FDA completed an inspection of Victoria E. Wang, MD, PhD on Jul 9, 2026 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 9, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Francisco, CA (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.